RKAGY OTC
RHÃN-KLINIKUM Aktiengesellschaft
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +7.4%
1Y: +10.7%
3Y: +21.6%
5Y: -12.5%
$8.16
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$1.8B
-2.1% ▼
5Y CAGR: +2.2%
Total Liabilities
$467M
-11.9% ▼
5Y CAGR: +1.2%
Shareholders Equity
$1.3B
+1.9% ▲
5Y CAGR: +2.5%
Cash & Investments
$330M
-22.7% ▼
5Y CAGR: +4.4%
Total Debt
$122M
-18.4% ▼
5Y CAGR: -5.3%
Net Debt
-$48M
+63.1% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $126M | $77M | $206M | $280M | $170M |
| Short-Term Investments | $173M | $228M | $137M | $147M | $160M |
| Cash & ST Investments | $300M | $305M | $343M | $427M | $330M |
| Net Receivables | $274M | $344M | $230M | $415M | $506M |
| Inventory | $33M | $33M | $34M | $37M | $41M |
| Other Current Assets | -$2M | $299K | $176M | $17M | $5M |
| Total Current Assets | $611M | $689M | $789M | $904M | $890M |
| Property, Plant & Equip. | $853M | $822M | $792M | $764M | $749M |
| Goodwill & Intangibles | $182M | $179M | $176M | $174M | $168M |
| Long-Term Investments | -$155M | -$214M | $13M | -$133M | $9M |
| Other Non-Current Assets | $175M | $228M | $8K | $14M | $0 |
| Total Non-Current Assets | $1.1B | $1.0B | $981M | $952M | $928M |
| Total Assets | $1.7B | $1.7B | $1.8B | $1.9B | $1.8B |
| — Liabilities — | |||||
| Accounts Payable | $72M | $70M | $67M | $64M | $75M |
| Short-Term Debt | $1M | $8M | $1M | $32M | $4M |
| Deferred Revenue | $159M | $150M | $0 | $0 | $5M |
| Other Current Liabilities | $9M | $35M | $243M | $280M | $152M |
| Total Current Liabilities | $273M | $291M | $335M | $405M | $342M |
| Long-Term Debt | $149M | $142M | $142M | $111M | $111M |
| Other Non-Current Liab. | $12M | $15M | $8M | $6M | $5M |
| Total Non-Current Liabilities | $168M | $162M | $155M | $126M | $126M |
| Total Liabilities | $441M | $454M | $490M | $531M | $467M |
| — Equity — | |||||
| Common Stock | $167M | $167M | $167M | $167M | $167M |
| Retained Earnings | $457M | $482M | $511M | $0 | $579M |
| Accumulated OCI | $178M | $178M | $0 | $0 | $0 |
| Total Stockholders Equity | $1.2B | $1.2B | $1.3B | $1.3B | $1.3B |
| Total Liabilities & Equity | $1.7B | $1.7B | $1.8B | $1.9B | $1.8B |
| — Key Metrics — | |||||
| Total Debt | $160M | $158M | $150M | $150M | $122M |
| Net Debt | $33M | $81M | -$56M | -$130M | -$48M |
| Total Investments | $18M | $14M | $150M | $14M | $169M |